Abstract
Background
Recurrent ovarian cancer is refractory and resistant to treatment in most patients, and no effective treatment for it has been established. Starting a treatment when tumors still consist of micro foci may contribute to improvement of prognosis. Therefore, the early diagnosis of relapse is important.
Methods
Among patients with epithelial ovarian cancer in whom initial treatment achieved remission between April 1998 and December 2003, those patients in whom the cancer-related antigen (CA)125 level was increased during the subsequent follow-up period, or those who showed abnormal computed tomography (CT)/magnetic resonance imaging (MRI) findings despite normal CA125 levels, were examined by 18F-fluoro-2-deoxyglucose – positron emission tomography (FDG-PET). We compared the rates of accurate diagnosis of recurrence achieved using CT/MRI, CA125, and FDG-PET in patients with a definitive diagnosis of relapse.
Results
We investigated 29 patients with epithelial ovarian cancer. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of FDG-PET were 84.6% (22/26), 100% (3/3), 100% (22/22), 42.9% (3/7), and 86.2% (25/29), respectively. These values were higher than the corresponding values obtained using CT/MRI or CA125 levels.
Conclusion
FDG-PET may be very useful for identifying sites of recurrent ovarian cancer, although this procedure had a low NPV because of the high rate of false-negative findings for micro or cystic lesions.
Article PDF
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
References
GJS Rustin AE Nelstrop MK Tuxen et al. (1996) ArticleTitleDefining progression of ovarian carcinoma during follow-up according to CA125: a North Thames Ovary Group study Ann Oncol 7 361–364 Occurrence Handle1:STN:280:BymA1MbktlA%3D Occurrence Handle8805927
GJS Rustin MEL van der Burg JS Berek (1993) ArticleTitleTumor markers Ann Oncol 4 IssueIDs4 S71–S77
B Patsner JW Orr SuffixJr WJ Mann et al. (1990) ArticleTitleDoes serum CA125 level prior to second look laparotomy for invasive ovarian adenocarcinoma predict size of residual disease Gynecol Oncol 38 373–376 Occurrence Handle10.1016/0090-8258(90)90076-W Occurrence Handle1:STN:280:By6D3szitVc%3D Occurrence Handle2227551
SC Rubin WJ Hoskins TB Hakes et al. (1989) ArticleTitleSerum CA125 Levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer Am J Obstet Gynecol 160 667–671 Occurrence Handle1:STN:280:BiaC1M%2FovVc%3D Occurrence Handle2648838
M Zimny W Siggelkow W Schroder et al. (2001) ArticleTitle2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer Gynecol Oncol 83 310–315 Occurrence Handle10.1006/gyno.2001.6386 Occurrence Handle1:STN:280:DC%2BD3MrmtVKgtA%3D%3D Occurrence Handle11606090
GJS Rustin A Nelstrop J Stilwell et al. (1992) ArticleTitleSaving obtained by CA125 measurements during therapy for ovarian carcinoma Eur J Cancer 28 79–82 Occurrence Handle10.1016/0959-8049(92)90390-N Occurrence Handle1:STN:280:By2B3s3ktlc%3D Occurrence Handle1567697
LG Strauss PS Conti (1991) ArticleTitleThe application of PET in clinical oncology J Nucl Med 32 623–648 Occurrence Handle1:STN:280:By6C1MzotVY%3D Occurrence Handle2013803
R Bar Shalom AY Valdivia MD Blaufox et al. (2000) ArticleTitlePET imaging in oncology Semin Nucl Med 3 150–185
R Tucker M Coel J Ko et al. (2001) ArticleTitleImpact of fluorine-18 fluorodeoxyglucose positron emission tomography on patient management: first year’s experience in a clinical center J Clin Oncol 19 2504–2508 Occurrence Handle1:STN:280:DC%2BD3MzgvFGksA%3D%3D Occurrence Handle11331329
PG Rose (2000) ArticleTitleSurgery for recurrent ovarian cancer Semin Oncol 3 IssueIDs7 17–23
SK Chambers JT Chambers EI Kohorn et al. (1988) ArticleTitleEvaluation of the role of second look surgery in ovarian cancer Obstet Gynecol 72 404–408 Occurrence Handle1:STN:280:BieA3c3ovFc%3D Occurrence Handle3405557
ME Potter KD Hatch SJ Soong et al. (1991) ArticleTitleSecond look laparotomy and salvage therapy: a research modality only? Gynecol Oncol 44 3–9 Occurrence Handle10.1016/0090-8258(92)90002-Z
RC Young (1987) ArticleTitleA second look at second look laparotomy J Clin Oncol 5 1311–1313 Occurrence Handle1:STN:280:BiiA3M%2FlvVQ%3D Occurrence Handle3625251
JB Friedman NS Weiss (1991) ArticleTitleSecond thoughts about second look laparotomy in advanced ovarian cancer N Engl J Med 322 1079–1080
JS Berek (1992) ArticleTitleSecond-Look versus second-nature Gynecol Oncol 44 1–2 Occurrence Handle10.1016/0090-8258(92)90001-Y Occurrence Handle1:STN:280:By2C3M3htVQ%3D Occurrence Handle1730414
H Meden W Rath D Ohlmeyer (1990) ArticleTitleThe value of preoperative diagnosis before second-look laparotomy in ovarian cancer Geburtshilfe Frauenheilkd 50 102–105
T Torizuka S Nobezawa T Kanno et al. (2002) ArticleTitleOvarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy-d-glucose Eur J Nucl Med 29 797–803 Occurrence Handle10.1007/s00259-001-0750-9 Occurrence Handle1:CAS:528:DC%2BD38XlvVWmsrY%3D
RF Yen S-S Sun Y-Y Shen et al. (2001) ArticleTitleWhole body positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer Anticancer Res 21 3691–3694 Occurrence Handle1:STN:280:DC%2BD387hsFWqsQ%3D%3D Occurrence Handle11848544
MEL van der Burg M van Lent (1995) ArticleTitleThe effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer N Engl J Med 332 629–934 Occurrence Handle10.1056/NEJM199503093321002 Occurrence Handle1:STN:280:ByqC2cjptlY%3D Occurrence Handle7845426
SM Eisenkop RL Friedman (2000) ArticleTitleThe role of second cytoreductive surgery in the treatment of patient with recurrent epithelial ovarian carcinoma Cancer 88 144–153 Occurrence Handle10.1002/(SICI)1097-0142(20000101)88:1<144::AID-CNCR20>3.0.CO;2-X Occurrence Handle1:STN:280:DC%2BD3c%2Fos1OmsA%3D%3D Occurrence Handle10618617
S Makhija P Sabbatini C Aghajanian et al. (1999) ArticleTitleIntraperitoneal cisplatin and intravenous paclitaxel in the treatment of epithelial ovarian patients with a positive second look Gynecol Oncol 79 28–32 Occurrence Handle10.1006/gyno.2000.5890
M Markman MF Brady NM Spirtos et al. (1998) ArticleTitlePhase II trial of intraperitoneal paclitaxel in carcinoma of the ovary, tube, and peritoneum: a gynecologic Oncology Group Study J Clin Oncol 16 2620–2624 Occurrence Handle1:CAS:528:DyaK1cXlsFCgur4%3D Occurrence Handle9704711
BY Karlan R Hawkins C Hoh et al. (1993) ArticleTitleWhole-body positron emission tomography with 2-[18F]-fluoro-2-deoxy-d-glucose can detect recurrent ovarian carcinoma Gynecol Oncol 51 175–181 Occurrence Handle10.1006/gyno.1993.1268 Occurrence Handle1:STN:280:ByuC3c3lvFM%3D Occurrence Handle8276290
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Takekuma, M., Maeda, M., Ozawa, T. et al. Positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer. Int J Clin Oncol 10, 177–181 (2005). https://doi.org/10.1007/s10147-005-0489-6
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10147-005-0489-6